# Bowhead Specialty Holdings Inc.: financial statements, quarterly

BOW · NYSE · CIK 2002473 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bow.md) · [Financials](/companies/bow/financials.md) · [Filings](/companies/bow/filings.md) · [Insiders](/companies/bow/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bow/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [76.1](/filings/0002002473-24-000015.md) | [82.8 d](/filings/0001628280-26-011089.md) | [90.7](/filings/0002002473-25-000040.md) | [98.9](/filings/0002002473-25-000061.md) | [117](/filings/0001628280-25-048878.md) | [119 d](/filings/0001628280-26-011089.md) | [123](/filings/0001628280-26-030616.md) | [133](/filings/0001628280-26-051847.md) | [144](/filings/0001628280-25-048878.md) | [152 d](/filings/0001628280-26-011089.md) | [156](/filings/0001628280-26-030616.md) | [164](/filings/0001628280-26-051847.md) |
| Income tax | $m | [2.6](/filings/0002002473-24-000015.md) | [1.0 d](/filings/0001628280-26-011089.md) | [2.0](/filings/0002002473-25-000040.md) | [1.9](/filings/0002002473-25-000061.md) | [3.7](/filings/0001628280-25-048878.md) | [4.6 d](/filings/0001628280-26-011089.md) | [3.0](/filings/0001628280-26-030616.md) | [3.6](/filings/0001628280-26-051847.md) | [3.9](/filings/0001628280-25-048878.md) | [3.0 d](/filings/0001628280-26-011089.md) | [4.6](/filings/0001628280-26-030616.md) | [4.5](/filings/0001628280-26-051847.md) |
| Net income | $m | [8.7](/filings/0002002473-24-000015.md) | [4.8 d](/filings/0001628280-26-011089.md) | [7.0](/filings/0001628280-25-048878.md) | [5.5](/filings/0001628280-25-048878.md) | [12.1](/filings/0001628280-25-048878.md) | [13.6 d](/filings/0001628280-26-011089.md) | [11.4](/filings/0001628280-26-051847.md) | [12.3](/filings/0001628280-26-051847.md) | [15.2](/filings/0001628280-25-048878.md) | [14.8 d](/filings/0001628280-26-011089.md) | [16.0](/filings/0001628280-26-051847.md) | [16.1](/filings/0001628280-26-051847.md) |
| Diluted EPS | $ per share | [0.36](/filings/0002002473-24-000015.md) | not reported | [0.29](/filings/0002002473-25-000040.md) | [0.20](/filings/0002002473-25-000061.md) | [0.36](/filings/0001628280-25-048878.md) | not reported | [0.34](/filings/0001628280-26-030616.md) | [0.36](/filings/0001628280-26-051847.md) | [0.45](/filings/0001628280-25-048878.md) | not reported | [0.48](/filings/0001628280-26-030616.md) | [0.48](/filings/0001628280-26-051847.md) |
| Basic EPS | $ per share | [0.36](/filings/0002002473-24-000015.md) | not reported | [0.29](/filings/0002002473-25-000040.md) | [0.20](/filings/0002002473-25-000061.md) | [0.37](/filings/0001628280-25-048878.md) | not reported | [0.35](/filings/0001628280-26-030616.md) | [0.38](/filings/0001628280-26-051847.md) | [0.46](/filings/0001628280-25-048878.md) | not reported | [0.49](/filings/0001628280-26-030616.md) | [0.49](/filings/0001628280-26-051847.md) |

- Revenue: us-gaap:Revenues
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [127](/filings/0002002473-24-000015.md) | [118](/filings/0001628280-26-011089.md) | [73.5](/filings/0002002473-25-000040.md) | [180](/filings/0002002473-25-000061.md) | [133](/filings/0001628280-25-048878.md) | [97.5](/filings/0001628280-26-011089.md) | [88.1](/filings/0001628280-26-030616.md) | [115](/filings/0001628280-26-051847.md) | [198](/filings/0001628280-25-048878.md) | [194](/filings/0001628280-26-051847.md) | [97.2](/filings/0001628280-26-030616.md) | [142](/filings/0001628280-26-051847.md) |
| Total assets | $m | not reported | [1,028](/filings/0002002473-25-000008.md) | not reported | [1,395](/filings/0001628280-24-036134.md) | [1,548](/filings/0002002473-24-000015.md) | [1,654](/filings/0001628280-26-011089.md) | [1,753](/filings/0002002473-25-000040.md) | [1,942](/filings/0002002473-25-000061.md) | [2,095](/filings/0001628280-25-048878.md) | [2,371](/filings/0001628280-26-051847.md) | [2,479](/filings/0001628280-26-030616.md) | [2,681](/filings/0001628280-26-051847.md) |
| Total liabilities | $m | not reported | [836](/filings/0002002473-25-000008.md) | not reported | [1,055](/filings/0001628280-24-036134.md) | [1,183](/filings/0002002473-24-000015.md) | [1,284](/filings/0001628280-26-011089.md) | [1,362](/filings/0002002473-25-000040.md) | [1,534](/filings/0002002473-25-000061.md) | [1,664](/filings/0001628280-25-048878.md) | [1,922](/filings/0001628280-26-051847.md) | [2,020](/filings/0001628280-26-030616.md) | [2,207](/filings/0001628280-26-051847.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-011089.md) | not reported | not reported | not reported | [146](/filings/0001628280-26-051847.md) | [147](/filings/0001628280-26-030616.md) | [147](/filings/0001628280-26-051847.md) |
| Shareholders' equity | $m | not reported | [192](/filings/0002002473-25-000008.md) | not reported | [340](/filings/0001628280-24-036134.md) | [365](/filings/0002002473-24-000015.md) | [370](/filings/0001628280-26-011089.md) | [391](/filings/0002002473-25-000040.md) | [407](/filings/0002002473-25-000061.md) | [430](/filings/0001628280-25-048878.md) | [448](/filings/0001628280-26-051847.md) | [458](/filings/0001628280-26-030616.md) | [472](/filings/0001628280-26-051847.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [88.3 d](/filings/0002002473-24-000015.md) | [61.4 d](/filings/0001628280-26-011089.md) | [41.9](/filings/0002002473-25-000040.md) | [71.5 d](/filings/0002002473-25-000061.md) | [119 d](/filings/0001628280-25-048878.md) | [61.4 d](/filings/0001628280-26-011089.md) | [47.7](/filings/0001628280-26-030616.md) | [109 d](/filings/0001628280-26-051847.md) | [115 d](/filings/0001628280-25-048878.md) | [60.1 d](/filings/0001628280-26-011089.md) | [65.5](/filings/0001628280-26-030616.md) | [93.9 d](/filings/0001628280-26-051847.md) |
| Capital expenditure | $m | [1.1 d](/filings/0002002473-24-000015.md) | [0.9 d](/filings/0001628280-26-011089.md) | [0.8](/filings/0002002473-25-000040.md) | [0.8 d](/filings/0002002473-25-000061.md) | [1.0 d](/filings/0001628280-25-048878.md) | [0.5 d](/filings/0001628280-26-011089.md) | [1.2](/filings/0001628280-26-030616.md) | [1.6 d](/filings/0001628280-26-051847.md) | [1.3 d](/filings/0001628280-25-048878.md) | [1.5 d](/filings/0001628280-26-011089.md) | [1.3](/filings/0001628280-26-030616.md) | [1.4 d](/filings/0001628280-26-051847.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2023-06-30) | period not labelled (2023-09-30) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.0](/filings/0001628280-24-036134.md) | [24.0](/filings/0002002473-24-000015.md) | [24.0](/filings/0002002473-25-000040.md) | [27.8](/filings/0002002473-25-000061.md) | [33.3](/filings/0001628280-25-048878.md) | [33.7](/filings/0001628280-26-030616.md) | [34.0](/filings/0001628280-26-051847.md) | [33.7](/filings/0001628280-25-048878.md) | [33.3](/filings/0001628280-26-030616.md) | [33.6](/filings/0001628280-26-051847.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 32,943,005 at 2026-07-29, from the cover of the [10-Q filed 2026-08-03](/filings/0001628280-26-051847.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.